Baxter International (BAX) Non-Current Assets (2009 - 2026)
Baxter International (BAX) posted quarterly Non-Current Assets of $12.8 billion for Q2 2026, down 10.46% year-over-year from $14.3 billion in Q2 2025, and down 1.52% quarter-over-quarter from $13.0 billion in Q1 2026.
Baxter International (BAX) Non-Current Assets (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Non-Current Assets for 18 consecutive years, with $12.8 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 10.46% year-over-year to $12.8 billion; the TTM figure through Jun 2026 stood at $53.1 billion (down 16.09% YoY), while the FY2025 annual figure was $13.2 billion, down 22.13% from the prior year.
- Non-Current Assets eased to $12.8 billion in Q2 2026 per BAX's latest filing, from $13.0 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $24.5 billion in Q1 2022 and bottomed at $12.8 billion in Q2 2026.
- Historically, Non-Current Assets has averaged $17.7 billion across 5 years, with a median of $18.1 billion in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 111.4% — and 2025, when it slipped 22.4%.
- Baxter International's Non-Current Assets stood at $20.3 billion in 2022, then decreased by 7.89% to $18.7 billion in 2023, then fell by 9.35% to $16.9 billion in 2024, then retreated by 22.13% to $13.2 billion in 2025, then declined by 2.89% to $12.8 billion in 2026.
- Business Quant data shows BAX's Non-Current Assets at $12.8 billion in Q2 2026, $13.0 billion in Q1 2026, and $13.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 3.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.80 Bn |
| Mar 31, 2026 | 13.00 Bn |
| Dec 31, 2025 | 13.18 Bn |
| Sep 30, 2025 | 14.13 Bn |
| Jun 30, 2025 | 14.30 Bn |
| Mar 31, 2025 | 14.27 Bn |
| Dec 31, 2024 | 16.93 Bn |
| Sep 30, 2024 | 17.81 Bn |
| Jun 30, 2024 | 17.72 Bn |
| Mar 31, 2024 | 18.39 Bn |
| Dec 31, 2023 | 18.68 Bn |
| Sep 30, 2023 | 18.62 Bn |
| Jun 30, 2023 | 19.68 Bn |
| Mar 31, 2023 | 20.19 Bn |
| Dec 31, 2022 | 20.28 Bn |
| Sep 30, 2022 | 20.16 Bn |
| Jun 30, 2022 | 23.95 Bn |
| Mar 31, 2022 | 24.54 Bn |
| Dec 31, 2021 | 24.65 Bn |
| Sep 30, 2021 | 11.64 Bn |